Thus, the objectives of this study were to compare serum TIMP-1 levels during the first week of a severe cerebral infarction between non-surviving and surviving patients and to determine whether those levels during the first week of a severe cerebral infarction could be used as a biomarker of early mortality. This evidence concerns the gene TIMP1 and cerebral infarction.